WCN26-3362 The safety and efficacy of a single dose of intravenous ferric carboxymaltose in patients undergoing hemodialysis: a multicenter, single-arm, open-label, clinical trial
20260 citationsJournal Articlegold Open Access
Field-Weighted Citation Impact: 0.00
WCN26-3362 The safety and efficacy of a single dose of intravenous ferric carboxymaltose in patients undergoing hemodialysis: a multicenter, single-arm, open-label, clinical trial | Researchclopedia